A detailed history of Ridgewood Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ridgewood Investments LLC holds 9,346 shares of NVO stock, worth $452,907. This represents 0.22% of its overall portfolio holdings.

Number of Shares
9,346
Previous 6,627 41.03%
Holding current value
$452,907
Previous $457,000 13.35%
% of portfolio
0.22%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

BUY
$45.38 - $71.7 $123,388 - $194,952
2,719 Added 41.03%
9,346 $518,000
Q2 2025

Jul 14, 2025

BUY
$58.08 - $81.05 $258,862 - $361,239
4,457 Added 205.39%
6,627 $457,000
Q1 2025

May 07, 2025

BUY
$69.3 - $90.95 $103,603 - $135,970
1,495 Added 221.48%
2,170 $150,000
Q4 2024

Jan 10, 2025

BUY
$85.0 - $120.04 $57,375 - $81,027
675 New
675 $58,000
Q1 2023

Apr 25, 2023

BUY
$132.34 - $159.14 $1,852 - $2,227
14 New
14 $2,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ridgewood Investments LLC Portfolio

Follow Ridgewood Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.